Fiesta Restaurant Group, Inc. (NASDAQ:FRGI), announced that Tim Taft, President and Chief Executive Officer, and Lynn Schweinfurth, Senior Vice President and Chief Financial Officer, will be presenting at the Raymond James 37th Annual Institutional Investors Conference at the Grande Lakes Orlando Resort in Florida. The presentation will begin at 1:40 PM Eastern Time on Tuesday, March 8, 2016.
Fiesta Restaurant Group, Inc. (NASDAQ:FRGI) belongs to Services sector. Its net profit margin is 7.00% and weekly performance is -3.66%. On last trading day company shares ended up at $35.56.
On February 26, 2016, Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA), issued a press release announcing that on February 15, 2016, it entered into a non-binding Letter of Intent (the “Letter of Intent”) with Grupo Ferrer Internacional, S.A. (“Ferrer”) with respect to Ferrer’s proposed acquisition of all outstanding shares of the Company’s common stock (the “Transaction”). A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) shares fell -14.41% in last trading session and ended the day at $0.54. ALXA return on assets is -61.10%. Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) quarterly performance is -48.07%.
On 01 March, Zion Oil & Gas, Inc. (NASDAQ:ZN) shares moved up 2.29% and was closed at $1.79. ZN EPS growth in last 5 year was 11.00%. Zion Oil & Gas, Inc. (NASDAQ:ZN) year to date (YTD) performance is -3.76%.
On 25 February, EnerNOC, Inc. (NASDAQ:ENOC) announced, for year ending December 31, 2016, the company expects GAAP net loss per share to be in the range of $3.85-$3.50, and total revenue in the range of $365-$395 million.
EnerNOC, Inc. (NASDAQ:ENOC) ended the last trading day at $6.21. Company weekly volatility is calculated as 13.43% and price to cash ratio as 1.35. EnerNOC, Inc. (NASDAQ:ENOC) showed a weekly performance of 19.88%.
On 25 February, Repligen Corporation (NASDAQ:RGEN) reported Non-GAAP adjusted net income for the fourth quarter of 2015 was $2.2 million, a year-over-year increase of $1.7 million. Adjusted net income excludes the impact of the aforementioned Refine contingent consideration expense in 2015 and 2014 and non-product revenue in 2014. On a GAAP basis, net income for the fourth quarter of 2015 was $265,000, an increase of $663,000 compared to a net loss of $398,000 for the fourth quarter of 2014.
Repligen Corporation (NASDAQ:RGEN) shares moved up 5.87% in last trading session and ended the day at $27.24. RGEN Gross Margin is 57.70% and its return on assets is 6.70%. Repligen Corporation (NASDAQ:RGEN) quarterly performance is -5.94%.